Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Janus

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Neuro-Oncology|April 4, 2003
A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant gliomaMichael D Prados, S Clifford Schold, Howard A Fine, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblastsKarim Fizazi, Jun Yang, Sara Peleg, et al.
Acta Orthopaedica|June 28, 2021
A roadmap to surgery in osteogenesis imperfecta: results of an international collaboration of patient organizations and interdisciplinary care teamsRalph J Sakkers, Kathleen Montpetit, Argerie Tsimicalis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2002
Atrasentan, an endothelin-receptor antagonist for refractory adenocarcinomas: safety and pharmacokineticsMichael A Carducci, Joel B Nelson, M Kathy Bowling, et al.
Molecular Neurodegeneration|June 1, 2012
LRRK2 knockout mice have an intact dopaminergic system but display alterations in exploratory and motor co-ordination behaviorsKelly M Hinkle, Mei Yue, Bahareh Behrouz, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|January 1, 1996
The CTFA Evaluation of Alternatives Program: an evaluation of in vitro alternatives to the Draize primary eye irritation test. (Phase III) surfactant-based formulationsS D Gettings, R A Lordo, K L Hintze, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Neuro-Oncology|April 4, 2003
A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant gliomaMichael D Prados, S Clifford Schold, Howard A Fine, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblastsKarim Fizazi, Jun Yang, Sara Peleg, et al.
Acta Orthopaedica|June 28, 2021
A roadmap to surgery in osteogenesis imperfecta: results of an international collaboration of patient organizations and interdisciplinary care teamsRalph J Sakkers, Kathleen Montpetit, Argerie Tsimicalis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2002
Atrasentan, an endothelin-receptor antagonist for refractory adenocarcinomas: safety and pharmacokineticsMichael A Carducci, Joel B Nelson, M Kathy Bowling, et al.
Molecular Neurodegeneration|June 1, 2012
LRRK2 knockout mice have an intact dopaminergic system but display alterations in exploratory and motor co-ordination behaviorsKelly M Hinkle, Mei Yue, Bahareh Behrouz, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|January 1, 1996
The CTFA Evaluation of Alternatives Program: an evaluation of in vitro alternatives to the Draize primary eye irritation test. (Phase III) surfactant-based formulationsS D Gettings, R A Lordo, K L Hintze, et al.
Pageof 7